Addex Therapeutics Ltd.
|Number of Estimates|
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Market Cap: 340 Million
Primary Exchange: NASDAQ
Shares Outstanding: 32.8 Million
Sector: Health Technology
Industry: Pharmaceuticals: Major
Longest drawdown: 115 trading days
From: 2020-01-31 To: 2020-07-14
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|